Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Knowing when to change your investment strategy is crucial. Discover key signs that indicate it's time to adapt.
24,241 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
June card spending rose 6.3% year over year, with wage gains across all income groups. The latest bofa consumer chief...
Home Depot and Lowe's are the two biggest players in home improvement. This article breaks down how their revenues ar...
With federal Medicaid work requirements looming, several states are pushing legislation to publicly name big employer...
Box and DocuSign sit at different corners of the SaaS world. This analysis shows how quarterly revenue patterns illum...
SpaceX is hovering around its $135 IPO price as investors digest post-debut dynamics. One broker, Raymond James, argu...
As summer approaches, markets sit near record levels while risk factors circulate. This piece outlines six actionable...
A coalition representing the crypto industry files a lawsuit to block Illinois' Digital Asset Tax Act, arguing the le...
Bitcoin trades within a broad range as traders watch a historic buy zone. ETF-driven liquidity and macro shifts could...
New Mexico is moving to fund universal child care for all families using a windfall from oil and gas revenues, backed...
Geneva hosts a fresh round of U.S.-Iran nuclear talks as regional tensions rise. Markets respond with shifts in oil p...
The Washington Post has canceled Book World, delivering a major shake-up in literary coverage. Readers bid farewell a...